A Controlled Comparison of Nitrazepam (‘Mogadon’) with Sodium Amylobarbitone as a Sleep-inducing Agent
- 1 September 1967
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 113 (502) , 1005-1008
- https://doi.org/10.1192/bjp.113.502.1005
Abstract
Nitrazepam (Mogadon), a benzodiazepine compound, chemically related to diazepam (Valium) and chlordiazepoxide (Librium) is a recently introduced sleep-inducing agent. Other studies (Baum et al., 1965; Fraser and Shepherd, 1966), found it to be both safe and effective. It is thought to induce sleep by “shielding the brain centre responsible for waking from emotioned stimuli”, and is therefore of particular interest for psychiatric illness. This study is a clinical comparison with sodium amylobarbitone, using a double-blind cross-over technique.Keywords
This publication has 2 references indexed in Scilit:
- Subjective assessment of pain and its relationship to the administration of analgesics in patients with advanced cancerJournal of Psychosomatic Research, 1966
- An Experimental Study of Atypical Phantom PainThe British Journal of Psychiatry, 1965